HF-OCT Imaging
DeviceSubjects undergo HF-OCT imaging of stenosed coronary arteries
NCT Number: NCT05312164
This is an on-label clinical study design intended for the collection of three different types of interventional procedural data using FDA-cleared cardiac catheterization technologies and drugs, each used according to its product labeling and standard practice of medicine.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Veteran's Administration Palo Alto, Palo Alto, California, United States
These devices and drugs are commonly used for patient evaluation during PCI procedures performed by Interventional Cardiologists. The three device technologies used in a single catheterization laboratory visit for assessment of the coronary arteries include:
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects undergo HF-OCT imaging of stenosed coronary arteries
Subjects undergo FFR physiology assessment of stenosed coronary arteries
Subjects undergo angiography imaging of stenosed coronary arteries
Time frame: 2 years
There are no efficacy or safety outcomes in this study. This study is a simple data collection study to help the sponsor develop next-generation HF-OCT software. Pressure wire data will be paired with HF-OCT images and angiography images for analysis to determine if the HF-OCT imaging technology can predict FFR physiology information from the OCT pullback.
Contact information is provided by the study sponsor or research team.
Gentuity, LLC
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07635407
Arterial Occlusive Diseases, Arteriosclerosis
Beijing, Beijing Municipality, China
View Trial DetailsNCT03588481
Cardiovascular Diseases, Coronary Disease
Incheon, South Korea
View Trial DetailsNCT07660419
Arterial Occlusive Diseases, Arteriosclerosis
Beijing, China
View Trial DetailsNCT06535568
Acute Coronary Syndrome, Antineoplastic Agents
Milan, MI, Italy
View Trial Details